Cargando…

A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma

BACKGROUND: Effective therapies for transitional cell carcinoma (TCC) are limited, with objective response rates to most chemotherapeutic regimens below 20%. The purpose of this study was to investigate the biologic activity of combined toceranib phosphate and vinblastine chemotherapy for treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rippy, Sarah B., Gardner, Heather L., Nguyen, Sandra M., Warry, Emma E., Portela, Roberta A., Drost, William Tod, Hostnik, Eric T., Green, Eric M., Chew, Dennis J., Peng, Juan, London, Cheryl A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114733/ https://www.ncbi.nlm.nih.gov/pubmed/27855679 http://dx.doi.org/10.1186/s12917-016-0882-6

Ejemplares similares

Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016)

Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
por: Gardner, Heather L., et al.
Publicado: (2015)

Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs
por: Olsen, Jaime A., et al.
Publicado: (2018)

Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose
por: Bernabe, Luis Feo, et al.
Publicado: (2013)

Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
por: Musser, Margaret L., et al.
Publicado: (2021)

Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia
por: Schuh, Elizabeth M., et al.
Publicado: (2017)

Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study
por: London, Cheryl A., et al.
Publicado: (2015)

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor
por: Halsey, Charles HC, et al.
Publicado: (2014)

A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas
por: Coto, Giovanna M., et al.
Publicado: (2021)

Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019)
por: Sheppard‐Olivares, Sabina, et al.
Publicado: (2022)

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
por: Regan, Daniel P., et al.
Publicado: (2022)

Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
por: Korec, Daniela I., et al.
Publicado: (2021)

Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma
por: Gardner, Heather L., et al.
Publicado: (2018)

Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone
por: Webster, Joshua D, et al.
Publicado: (2008)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)
por: Musser, Margaret L., et al.
Publicado: (2018)

Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway
por: Kobayashi, Priscila E., et al.
Publicado: (2020)

Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
por: Tjostheim, S.S., et al.
Publicado: (2016)

Characterizing the metabolic role of STAT3 in canine osteosarcoma
por: Gardner, Heather L., et al.
Publicado: (2022)

Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs
por: YAMAZAKI, Hiroki, et al.
Publicado: (2017)

Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
por: Heaton, Caitlin M., et al.
Publicado: (2020)

Vinblastine in the treatment of Hodgkin's disease.
por: Jelliffe, A. M.
Publicado: (1969)

Inhibition of interferon secretion by vinblastine
por: Havell, EA, et al.
Publicado: (1975)

Vinblastine-induced Acral Hyperpigmentation
por: Chakraborti, Annesha, et al.
Publicado: (2020)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
por: Yamazaki, Hiroki, et al.
Publicado: (2020)

Toceranib phosphate-associated nephrotic syndrome in a dog: a case report
por: Remerowski, Shannon M., et al.
Publicado: (2021)

Vinblastine Sulphate in the Treatment of Malignant Disease
por: Bleehen, N. M., et al.
Publicado: (1965)

THE EFFECTS OF VINBLASTINE ON ISOLATED XENOPUS OOCYTES
por: Dumont, James N., et al.
Publicado: (1972)

Modifications on the Basic Skeletons of Vinblastine and Vincristine
por: Keglevich, Péter, et al.
Publicado: (2012)

Vinblastine: Neutropenia and thrombocytopenia: case report
Publicado: (2021)

A canine case of malignant melanoma carrying a KIT c.1725_1733del mutation treated with toceranib: a case report and in vitro analysis
por: Tani, Hiroyuki, et al.
Publicado: (2021)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
por: Berger, Erika P., et al.
Publicado: (2018)

Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma
por: OSADA, Hironari, et al.
Publicado: (2023)

Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
por: KISHI, Kazuhisa, et al.
Publicado: (2023)

A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma
por: Knapp, Deborah W., et al.
Publicado: (2016)

Regulation of initial vinblastine influx by P-glycoprotein.
por: Shalinsky, D. R., et al.
Publicado: (1993)

STRUCTURE OF MICROTUBULAR CRYSTALS INDUCED BY VINBLASTINE IN VITRO
por: Marantz, Robert, et al.
Publicado: (1970)

Effect of tau on the vinblastine-induced aggregation of tubulin
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_uhs7p89fc8r462nr8ego01tfi0